Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Leukemia

  Free Subscription


29.11.2021

1 Acta Haematol
2 Am J Hematol
17 Blood
1 Br J Haematol
1 Cancer Chemother Pharmacol
1 Exp Hematol
1 Int J Hematol
2 J Biol Chem
2 Leuk Lymphoma
1 Leuk Res
1 Leukemia
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. PLOTKA A, Lewandowski K
    BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy.
    Acta Haematol. 2021 Nov 24:1-9. doi: 10.1159/000519782.
    PubMed         Abstract available


    Am J Hematol

  2. SANTOS FM, Ghelfond G, Seguro FS, Abdo ANR, et al
    Analyzing the impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.
    Am J Hematol. 2021 Nov 25. doi: 10.1002/ajh.26424.
    PubMed        

  3. POPOVIC R, Dunbar F, Lu C, Robinson K, et al
    Identification of recurrent genomic alterations in the apoptotic machinery in chronic lymphocytic leukemia patients treated with venetoclax monotherapy.
    Am J Hematol. 2021 Nov 14. doi: 10.1002/ajh.26411.
    PubMed        


    Blood

  4. MORENO C
    Autoimmune cytopenia and CLL ride together.
    Blood. 2021;137:3464-3465.
    PubMed        

  5. MULLER MR
    A new option for Richter syndrome.
    Blood. 2021;137:3318-3319.
    PubMed        

  6. SMOLEJ L
    On the road to optimized BTK inhibition in CLL.
    Blood. 2021;137:3313-3314.
    PubMed        

  7. LOKE J, Cockerill PN
    Unravelling the apoptotic machinery in CMML.
    Blood. 2021;137:3321-3322.
    PubMed        

  8. WILLIAMS KM
    Checkpoint-blocked T cells checkmate AML.
    Blood. 2021;137:3155-3156.
    PubMed        

  9. HERLING M, Braun T
    Tracing the roots of CLPD-NK by TET2 and STAT3.
    Blood. 2021;137:3156-3158.
    PubMed        

  10. KORTYLEWSKI M
    Revisiting TLR9 as a target for CLL therapy.
    Blood. 2021;137:3006-3008.
    PubMed        

  11. TABE Y, Konopleva M
    Break the lifeline of AML cells.
    Blood. 2021;137:3465-3467.
    PubMed        

  12. LINLEY AJ, Slupsky JR
    Poor prognosis is ZAP70'ed into focus in CLL.
    Blood. 2021;137:3586-3587.
    PubMed        

  13. ROEKER LE, Eyre TA, Thompson MC, Lamanna N, et al
    COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
    Blood. 2021;138:1768-1773.
    PubMed        

  14. SCHILLER G
    A slow-go prognosis for older patients with newly diagnosed AML.
    Blood. 2021;138:501-502.
    PubMed        

  15. BURGER JA
    CLL cells are moved by the MARCKS brothers.
    Blood. 2021;138:503-504.
    PubMed        

  16. DERECKA M
    AML onco-niche: villain or ally?
    Blood. 2021;138:504-506.
    PubMed        

  17. HAN C, Ntziachristos P
    T-ALL and the talented Mr IL7Ralpha.
    Blood. 2021;138:1003-1004.
    PubMed        

  18. PALLASCH CP
    Cell cycle control in Richter transformation.
    Blood. 2021;138:1005-1007.
    PubMed        

  19. ISHIO T, Kumar S, Shimono J, Daenthanasanmak A, et al
    Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in Adult T-cell leukemia/lymphoma.
    Blood. 2021 Nov 24. pii: 482776. doi: 10.1182/blood.2021012734.
    PubMed         Abstract available

  20. SCHWALLER J
    MLL-AF4+ infant leukemia: a microRNA affair.
    Blood. 2021;138:2014-2015.
    PubMed        


    Br J Haematol

  21. BENDA M, Mutschlechner B, Ulmer H, Grabher C, et al
    Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients.
    Br J Haematol. 2021;195:523-531.
    PubMed         Abstract available


    Cancer Chemother Pharmacol

  22. YOSHIDA K, Fujita A, Narazaki H, Asano T, et al
    Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms.
    Cancer Chemother Pharmacol. 2021 Nov 26. pii: 10.1007/s00280-021-04373.
    PubMed         Abstract available


    Exp Hematol

  23. KENSWIL KJG, Pisterzi P, Feyen J, Ter Borg M, et al
    Immune composition and its association with hematologic recovery after chemotherapeutic injury in acute myeloid leukemia.
    Exp Hematol. 2021 Nov 17. pii: S0301-472X(21)00426.
    PubMed         Abstract available


    Int J Hematol

  24. KOBAYASHI S, Sano H, Mochizuki K, Ohara Y, et al
    Effects of second transplantation with T-cell-replete haploidentical graft using low-dose anti-thymocyte globulin on long-term overall survival in pediatric patients with relapse of leukemia after first allogeneic transplantation.
    Int J Hematol. 2021 Nov 25. pii: 10.1007/s12185-021-03266.
    PubMed         Abstract available


    J Biol Chem

  25. BOWEN NE, Temple J, Shepard C, Oo A, et al
    Structural and functional characterization explains loss of dNTPase activity of the cancer-specific R366C/H mutant SAMHD1 proteins.
    J Biol Chem. 2021;297:101170.
    PubMed         Abstract available

  26. SHEN H, Gonskikh Y, Stoute J, Liu KF, et al
    Human DIMT1 generates N2(6,6)A-dimethylation-containing small RNAs.
    J Biol Chem. 2021;297:101146.
    PubMed         Abstract available


    Leuk Lymphoma

  27. PRZESPOLEWSKI AC, Portwood S, Wang ES
    Targeting acute myeloid leukemia through multimodal immunotherapeutic approaches.
    Leuk Lymphoma. 2021 Nov 25:1-10. doi: 10.1080/10428194.2021.1992614.
    PubMed         Abstract available

  28. PALMIERI R, Buccisano F, Arena V, Irno Consalvo MA, et al
    CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia.
    Leuk Lymphoma. 2021 Nov 21:1-5. doi: 10.1080/10428194.2021.2005042.
    PubMed        


    Leuk Res

  29. MIRFAKHRAIE R, Noorazar L, Mohammadian M, Hajifathali A, et al
    Treatment Failure in Acute Myeloid Leukemia: Focus on the Role of Extracellular Vesicles.
    Leuk Res. 2021;112:106751.
    PubMed         Abstract available


    Leukemia

  30. SHIMOMURA Y, Sobue T, Hirabayashi S, Kondo T, et al
    Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia.
    Leukemia. 2021 Nov 24. pii: 10.1038/s41375-021-01474.
    PubMed         Abstract available


    PLoS One

  31. CARDOSO BORGES F, Ramos A, Lourenco A, Gomes da Silva M, et al
    Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
    PLoS One. 2021;16:e0258423.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: